MIG
BLUE

Mariner Investment Group’s bluebird bio BLUE Stock Holding History

Mariner Investment Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-772
Closed -$2K – 204
2015
Q3 		$2K Buy
+772
New +$1.41M ﹤0.01% 192

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mariner Investment Group's BLUE Position: Q3 2016 in Review

Mariner Investment Group sold out of bluebird bio (BLUE) in Q3 2016, closing a stake of 1,629 shares — an estimated $913K sold.

Mariner Investment Group first reported a position in BLUE in Q1 2015 and held it in 5 quarters. The position peaked at $2.18M in Q4 2015. 200 funds tracked by Wall St. Rank hold BLUE as of Q3 2016.

  • Mariner Investment Group reported no remaining bluebird bio position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 1,629 bluebird bio shares in Q3 2016, an estimated $913K.
  • Mariner Investment Group first reported a position in bluebird bio in Q1 2015 and held it in 5 quarters.
  • Mariner Investment Group's bluebird bio position peaked at $2.18M in Q4 2015.
  • 200 funds tracked by Wall St. Rank held bluebird bio as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.